Albert Kligman: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 2: | Line 2: | ||
{{Use mdy dates|date=October 2023}} | {{Use mdy dates|date=October 2023}} | ||
'''Albert Montgomery Kligman''' (March 17, 1916 – February 9, 2010) was an American [[dermatologist]] and | ==Albert Kligman== | ||
[[File:Albert_Kligman11.jpg|thumb|right|Albert Kligman]] | |||
'''Albert Montgomery Kligman''' (March 17, 1916 – February 9, 2010) was an American [[dermatologist]] and researcher known for his work in the field of dermatology, particularly for the development of [[tretinoin]] (Retin-A) for the treatment of [[acne]] and [[photoaging]]. | |||
==Early | ==Early Life and Education== | ||
Albert Kligman was born in [[Philadelphia]], [[Pennsylvania]]. He attended [[University of Pennsylvania]], where he earned his undergraduate degree. Kligman | Albert Kligman was born in [[Philadelphia]], [[Pennsylvania]]. He attended [[University of Pennsylvania]], where he earned his undergraduate degree. Kligman continued his education at the same institution, obtaining a Ph.D. in [[botany]] and later an M.D. from the University of Pennsylvania School of Medicine. | ||
==Career== | ==Career== | ||
Kligman began his career in dermatology at the University of Pennsylvania, where he conducted research on skin diseases and treatments. | Kligman began his career in dermatology at the University of Pennsylvania, where he conducted research on skin diseases and treatments. His work led to significant advancements in the understanding and treatment of various dermatological conditions. | ||
===Tretinoin | ===Development of Tretinoin=== | ||
Kligman is best known for his development of tretinoin, a derivative of [[vitamin A]] that became widely used in the treatment of acne and skin aging. Tretinoin was initially developed as a treatment for acne, but Kligman discovered its efficacy in reducing wrinkles and improving skin texture, leading to its use in anti-aging products. | |||
==Controversies== | ==Controversies== | ||
Kligman's career was not without controversy. He conducted research on inmates at | Kligman's career was not without controversy. He conducted research on inmates at [[Holmesburg Prison]] in Philadelphia, which later raised ethical concerns regarding informed consent and the treatment of human subjects in medical research. These studies were part of a broader pattern of medical experimentation on vulnerable populations during the mid-20th century. | ||
==Legacy== | ==Legacy== | ||
Despite the controversies, Kligman's contributions to dermatology | Despite the controversies, Kligman's contributions to dermatology have had a lasting impact. His work on tretinoin has helped millions of people manage acne and improve skin health. Kligman published numerous papers and was a respected figure in dermatological research. | ||
==Related pages== | ==Related pages== | ||
* [[Dermatology]] | * [[Dermatology]] | ||
* [[Tretinoin]] | * [[Tretinoin]] | ||
* [[ | * [[Acne]] | ||
* [[Photoaging]] | |||
* [[Holmesburg Prison experiments]] | * [[Holmesburg Prison experiments]] | ||
[[Category:American dermatologists]] | |||
[[Category:1916 births]] | [[Category:1916 births]] | ||
[[Category:2010 deaths]] | [[Category:2010 deaths]] | ||
[[Category: | [[Category:University of Pennsylvania alumni]] | ||
[[Category:University of Pennsylvania faculty]] | [[Category:University of Pennsylvania faculty]] | ||
Latest revision as of 11:35, 15 February 2025
American dermatologist and researcher
Albert Kligman[edit]
Albert Montgomery Kligman (March 17, 1916 – February 9, 2010) was an American dermatologist and researcher known for his work in the field of dermatology, particularly for the development of tretinoin (Retin-A) for the treatment of acne and photoaging.
Early Life and Education[edit]
Albert Kligman was born in Philadelphia, Pennsylvania. He attended University of Pennsylvania, where he earned his undergraduate degree. Kligman continued his education at the same institution, obtaining a Ph.D. in botany and later an M.D. from the University of Pennsylvania School of Medicine.
Career[edit]
Kligman began his career in dermatology at the University of Pennsylvania, where he conducted research on skin diseases and treatments. His work led to significant advancements in the understanding and treatment of various dermatological conditions.
Development of Tretinoin[edit]
Kligman is best known for his development of tretinoin, a derivative of vitamin A that became widely used in the treatment of acne and skin aging. Tretinoin was initially developed as a treatment for acne, but Kligman discovered its efficacy in reducing wrinkles and improving skin texture, leading to its use in anti-aging products.
Controversies[edit]
Kligman's career was not without controversy. He conducted research on inmates at Holmesburg Prison in Philadelphia, which later raised ethical concerns regarding informed consent and the treatment of human subjects in medical research. These studies were part of a broader pattern of medical experimentation on vulnerable populations during the mid-20th century.
Legacy[edit]
Despite the controversies, Kligman's contributions to dermatology have had a lasting impact. His work on tretinoin has helped millions of people manage acne and improve skin health. Kligman published numerous papers and was a respected figure in dermatological research.
